Your guide to fragment-based drug discovery

9 March 2021 , Brought to you by NanoTemper
Posted in DDW eBooks & eReports

Fragment-based drug discovery (FBDD) is one of the most popular approaches for finding lead compounds and it is becoming more widely adopted by pharma companies. FBDD is the solution researchers turn to when faced with challenging targets that call for compound libraries that offer more diverse molecules — especially from new chemical spaces. More importantly, FBDD has shown to improve hit rates and deliver higher-value targets.

NanoTemper has produced an eBook on FBDD.

This eBook will explain:

  • The advantages of FBDD over high-throughput screening
  • The top biophysical methods used in FBDD
  • What the future holds for FBDD

Suggested Reading

Webinar: Introduction into Fragment Based Drug Discovery
28 September 2022

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free